NFKB1 and Parkinson disease: Niacin (VitB3) shows potent anti-inflammatory activity through its receptor GPR109A by inhibiting the nuclear translocation of NF-κB in a lipopolysaccharide (LPS)-induced RAW264.7 cell model of PD.